Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LVO | -0.02% | $69.76M | -62.77% | 0.00% |
OGI | -0.02% | $130.00M | -52.09% | 0.00% |
ANGO | -0.03% | $384.42M | +61.84% | 0.00% |
MNSO | 0.03% | $5.74B | -9.37% | 1.49% |
NERV | -0.03% | $12.66M | -29.84% | 0.00% |
NNDM | -0.04% | $368.32M | -39.68% | 0.00% |
ASH | -0.04% | $2.78B | -39.40% | 2.76% |
SCCO | 0.05% | $74.95B | -8.99% | 2.20% |
BBD | 0.05% | $12.01B | -15.10% | 1.81% |
TIGR | -0.06% | $1.31B | +152.03% | 0.00% |
COHU | 0.06% | $705.32M | -54.70% | 0.00% |
GDOT | -0.08% | $453.36M | -10.40% | 0.00% |
KIDS | -0.08% | $600.85M | -15.16% | 0.00% |
ATUS | -0.11% | $1.28B | +6.13% | 0.00% |
TPST | -0.12% | $33.70M | -80.25% | 0.00% |
CLF | -0.12% | $4.21B | -62.53% | 0.00% |
AMRC | 0.13% | $649.41M | -48.78% | 0.00% |
KTOS | 0.14% | $4.69B | +66.92% | 0.00% |
GPCR | -0.15% | $1.13B | -53.87% | 0.00% |
AFRM | 0.15% | $14.79B | +23.99% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DOX | 41.13% | $10.20B | +0.64% | 1.59% |
JNJ | 39.67% | $394.52B | +3.49% | 3.02% |
CSGS | 35.66% | $1.72B | +15.50% | 2.06% |
BMY | 35.23% | $122.13B | +10.68% | 4.04% |
CTSH | 35.08% | $37.54B | +3.56% | 1.60% |
ADP | 33.81% | $122.40B | +20.46% | 1.95% |
PAYX | 32.50% | $54.38B | +22.99% | 2.58% |
WPC | 32.12% | $13.72B | +11.09% | 4.20% |
WMK | 31.89% | $2.08B | +20.02% | 1.77% |
VTRS | 31.71% | $10.36B | -27.30% | 5.60% |
JKHY | 31.06% | $13.02B | +2.80% | 1.25% |
KLG | 31.02% | $1.68B | +3.72% | 3.30% |
PFE | 30.31% | $142.98B | -9.15% | 6.81% |
PEP | 30.26% | $204.72B | -14.71% | 3.60% |
ACN | 30.17% | $190.52B | -12.20% | 1.83% |
INCY | 30.13% | $11.73B | +6.37% | 0.00% |
FDS | 29.88% | $17.07B | -1.24% | 0.93% |
MCRI | 29.41% | $1.45B | +4.53% | 1.55% |
PCH | 28.90% | $3.53B | -4.68% | 4.03% |
UAA | 28.87% | $2.71B | -14.63% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FLOT | <0.01% | $8.93B | 0.15% |
AIQ | 0.03% | $2.99B | 0.68% |
BSCP | 0.05% | $3.67B | 0.1% |
TOTL | 0.05% | $3.49B | 0.55% |
IBMS | 0.06% | $44.14M | 0.18% |
QTEC | 0.07% | $3.51B | 0.57% |
FXN | -0.08% | $333.06M | 0.62% |
PIN | 0.09% | $230.44M | 0.78% |
ARKQ | 0.12% | $859.91M | 0.75% |
DBB | -0.17% | $125.53M | 0.77% |
GBIL | 0.20% | $6.30B | 0.12% |
ICSH | -0.24% | $5.65B | 0.08% |
XSD | 0.27% | $1.09B | 0.35% |
YEAR | -0.28% | $1.27B | 0.25% |
MEAR | 0.30% | $824.64M | 0.25% |
PZA | -0.36% | $2.94B | 0.28% |
TAXF | -0.37% | $513.85M | 0.29% |
TAIL | -0.39% | $84.36M | 0.59% |
FEPI | -0.40% | $446.03M | 0.65% |
XOP | 0.42% | $2.31B | 0.35% |
Yahoo
The resignation of one of the FDA's top officials, Peter Marks, is worrying Wall Street as they await a replacement.
Yahoo
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 11.1%. This drop was worse than the S&P 500’s 4% decline.
SeekingAlpha
Hartford Quality Value ETF underperformed the Russell 1000 Value Index during the quarter. Read more here.
SeekingAlpha
Earn A Potentially 12%-15% Income: Monthly Options Series (April 2025)
SeekingAlpha
Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets. Find out which is the better bargain for investors.
SeekingAlpha
The equity portion of the Abrdn Life Sciences Investors Fund fell (gross) but outperformed its benchmark for Q4 2024. Click here to read the full commentary.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
EQLS | -23.55% | $4.74M | 1% |
DBA | -17.04% | $823.19M | 0.93% |
TBLL | -15.70% | $2.07B | 0.08% |
SMH | -11.56% | $19.68B | 0.35% |
KRBN | -10.15% | $172.54M | 0.85% |
VRIG | -9.86% | $1.42B | 0.3% |
CLSE | -9.33% | $168.71M | 1.55% |
SGOV | -9.27% | $39.32B | 0.09% |
TBIL | -9.14% | $5.33B | 0.15% |
PSI | -9.13% | $612.45M | 0.56% |
USCI | -9.00% | $232.14M | 1.07% |
AGZD | -8.97% | $136.43M | 0.23% |
USL | -8.55% | $47.09M | 0.85% |
DBO | -8.54% | $199.76M | 0.77% |
DBE | -8.31% | $54.74M | 0.77% |
USDU | -8.09% | $213.62M | 0.5% |
BNO | -8.07% | $96.15M | 1% |
GSG | -7.81% | $1.04B | 0.75% |
OILK | -7.78% | $67.10M | 0.69% |
FFOG | -7.61% | $111.85M | 0.55% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BBH | 41.13% | $371.52M | 0.35% |
IBB | 40.14% | $5.96B | 0.45% |
FDL | 39.16% | $5.31B | 0.45% |
HDV | 37.06% | $11.25B | 0.08% |
FHLC | 37.02% | $2.70B | 0.084% |
IHE | 36.81% | $605.75M | 0.39% |
XLV | 36.46% | $38.29B | 0.09% |
VHT | 36.31% | $16.46B | 0.09% |
SCHD | 36.21% | $70.23B | 0.06% |
SDOG | 35.87% | $1.23B | 0.36% |
RSPH | 35.79% | $796.40M | 0.4% |
IYK | 35.68% | $1.51B | 0.4% |
DHS | 35.56% | $1.23B | 0.38% |
USMV | 35.45% | $23.93B | 0.15% |
PINK | 35.26% | $142.47M | 0.5% |
LVHD | 35.25% | $541.84M | 0.27% |
IYH | 35.04% | $3.19B | 0.39% |
SPHD | 34.90% | $3.53B | 0.3% |
ACWV | 34.86% | $3.37B | 0.2% |
FVD | 34.34% | $9.14B | 0.6% |
Current Value
$111.151 Year Return
Current Value
$111.151 Year Return
Double maintains 13 strategies that include GILD - Gilead Sciences, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
VRT | -24.89% | $28.27B | -9.09% | 0.18% |
NVDA | -21.61% | $2.68T | +21.38% | 0.04% |
FIX | -20.26% | $11.52B | +2.01% | 0.43% |
CAMT | -20.18% | $2.69B | -29.57% | 0.00% |
ETN | -17.97% | $107.41B | -12.32% | 1.44% |
ONTO | -17.26% | $6.01B | -32.59% | 0.00% |
PSTG | -16.89% | $15.01B | -11.52% | 0.00% |
EME | -16.47% | $16.86B | +5.90% | 0.28% |
VST | -16.38% | $40.50B | +70.93% | 0.77% |
VITL | -15.82% | $1.32B | +27.83% | 0.00% |
TT | -15.54% | $74.46B | +10.59% | 1.05% |
CDNS | -15.53% | $70.36B | -17.54% | 0.00% |
BE | -15.26% | $4.69B | +80.87% | 0.00% |
ANET | -15.04% | $98.29B | +7.51% | 0.00% |
DELL | -15.00% | $64.40B | -19.12% | 1.99% |
VECO | -14.92% | $1.18B | -42.05% | 0.00% |
TSM | -14.90% | $856.97B | +21.46% | 1.53% |
WDC | -14.53% | $14.13B | -21.22% | 0.00% |
GEV | -14.49% | $83.58B | +121.52% | 0.00% |
NVT | -14.48% | $8.73B | -29.83% | 1.50% |